Peregrine Pharmaceuticals reported $159.69M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.2M 119.31M
Adamas Pharmaceuticals ADMS:US 88.8M 36.03M
Agenus AGEN:US $ 73.54M 45.82M
Amgen AMGN:US $ 6630M 518M
AstraZeneca AZN:LN 15567M 7931M
Biocryst Pharmaceuticals BCRX:US $ 218.43M 8.47M
Bristol Myers Squibb BMY:US $ 11024M 42M
Celldex Therapeutics CLDX:US $ 43.45M 25.87M
Chemocentryx CCXI:US $ 77.2M 8.66M
Dicerna Pharmaceuticals DRNA:US $ 221.21M 62.1M
Eli Lilly And LLY:US $ 3220M 217.6M
Flexion Therapeutics FLXN:US $ 107.63M 8.92M
GlaxoSmithKline GSK:LN 3503M 1254M
Immunogen IMGN:US $ 239.54M 43.58M
Intrexon XON:US $ 36.41M 9.06M
Karyopharm Therapeutics KPTI:US $ 141.31M 52.84M
Kindred Biosciences KIN:US $ 46.72M 33.8M
Macrogenics MGNX:US $ 188.97M 29.53M
Mannkind MNKD:US $ 62.52M 185.31M
Minerva Neurosciences NERV:US $ 74.22M 5.92M
Newlink Genetics NLNK:US $ 107.7M 6.4M
Novartis NOVN:VX SF 5117M 1316M
Novavax NVAX:US $ 238.03M 4.68M
Peregrine Pharmaceuticals PPHM:US $ 159.69M 10.22M
Repligen RGEN:US $ 734.33M 23.01M
Xencor XNCR:US $ 115.84M 61.12M